EXELIXIS, INC. 8-K

What Happened
On May 26, 2026, Exelixis, Inc. (EXEL) held its 2026 Annual Meeting (via webcast) and filed an 8‑K on May 29, 2026 reporting the results. Stockholders approved an amendment and restatement of the Exelixis 2017 Equity Incentive Plan, which became effective immediately upon approval. The company also reported the election of 11 directors and ratified Ernst & Young LLP as its independent registered public accounting firm.

Key Details

• 2017 Equity Incentive Plan: Approved at the Annual Meeting; summary of terms is in the Proxy Statement filed April 15, 2026. Vote: 196,926,657 FOR, 9,343,837 AGAINST, 319,812 ABSTAIN. The full plan is filed as Exhibit 10.1 to the 8‑K.
• Director elections: 11 directors were elected to serve until the 2027 annual meeting. Elected directors include Mary C. Beckerle, S. Gail Eckhardt, Maria C. Freire, Tomas J. Heyman, David E. Johnson, Michael M. Morrissey, Robert L. Oliver Jr., Stelios Papadopoulos, George Poste, Julie Anne Smith, and Jack L. Wyszomierski (vote tallies reported in the filing).
• Auditor ratification: Stockholders ratified Ernst & Young LLP for fiscal year ending Jan 1, 2027. Vote: 222,343,120 FOR, 6,485,691 AGAINST, 197,575 ABSTAIN.
• Advisory Say-on-Pay: The compensation of named executive officers was approved on an advisory basis. Vote: 163,104,135 FOR, 43,156,553 AGAINST, 329,618 ABSTAIN. Broker non-votes were reported at 22,436,080 for several matters.

Why It Matters
Approval of the amended 2017 Equity Incentive Plan formally authorizes the company’s updated framework for equity awards (stock options, restricted stock, and similar awards) to employees and directors. For investors, this relates to how Exelixis grants long‑term incentives and the potential for future share-based compensation (and associated dilution), so the plan text and Proxy provide important details. The re-election of the board and ratification of the auditor confirm continuity of Exelixis’ governance and financial reporting team following the Annual Meeting.